Cargando…
Strategy for genetic testing in Charcot-Marie-Disease
BACKGROUND: Charcot Marie Tooth disease (CMT) affects one in 2500 people. Genetic testing is often pursued for family planning purposes, natural history studies and for entry into clinical trials. However, identifying the genetic cause of CMT can be expensive and confusing to patients and physicians...
Autores principales: | Miller, L.J., Saporta, A.S.D., Sottile, S.L., Siskind, C.E., Feely, S.M.E., Shy, M.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SpA
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235845/ https://www.ncbi.nlm.nih.gov/pubmed/22106713 |
Ejemplares similares
-
Activation of NF-kB pathway in Duchenne
muscular dystrophy: relation to age
por: MESSINA, S., et al.
Publicado: (2011) -
HIV-related neuromuscular diseases:
nemaline myopathy, amyotrophic lateral
sclerosis and bibrachial amyotrophic diplegia
por: ROWLAND, L.P.
Publicado: (2011) -
Clinical, morphological and genetic studies
in a cohort of 21 patients with myofibrillar
myopathy
por: Vattemi, G., et al.
Publicado: (2011) -
Hereditary inclusion-body myopathy
with sparing of the quadriceps:
the many tiles of an incomplete puzzle
por: Broccolini, A., et al.
Publicado: (2011) -
Mesoangioblasts of inclusion-body myositis:
a twofold tool to study pathogenic mechanisms
and enhance defective muscle regeneration
por: MOROSETTI, R., et al.
Publicado: (2011)